Source:http://linkedlifedata.com/resource/pubmed/id/21732929
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-8-12
|
pubmed:abstractText |
Thalassaemia is characterized by the reduced or absent production of globins in the haemoglobin molecule leading to imbalanced ?-globin/non ?-globin chains. HbE, the result of a G to A mutation in codon 26 of the HBB (?-globin) gene, activates a cryptic 5' splice site in codon 25 leading to a reduction of correctly spliced ?(E) -globin (HBB:c.79G>A) mRNA and consequently ?(+) -thalassaemia. A wide range of clinical severities in both?- and ?-thalassaemia syndromes, from nearly asymptomatic to transfusion-dependent, has been observed. The correlation between clinical heterogeneity in various genotypes of thalassaemia and the levels of globin gene expression and ?(E) -globin pre-mRNA splicing were examined using multiplex quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR) and allele-specific RT-qPCR. The ?-globin/non ?-globin mRNA ratio was demonstrated to be a good indicator for disease severity among different thalassaemia disorders. However, the ?-globin/non ?-globin mRNA ratio ranged widely in ?-thalassaemia/HbE patients, with no significant difference between mild and severe phenotypes. Interestingly, the correctly to aberrantly spliced ?(E) -globin mRNA ratio in 30% of mild ?-thalassaemia/HbE patients was higher than that of the severe patients. The splicing process of ?(E) -globin pre-mRNA differs among ?-thalassaemia/HbE patients and serves as one of the modifying factors for disease severity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1365-2141
|
pubmed:author | |
pubmed:copyrightInfo |
© 2011 Blackwell Publishing Ltd.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
154
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
635-43
|
pubmed:meshHeading |
pubmed-meshheading:21732929-Adolescent,
pubmed-meshheading:21732929-Case-Control Studies,
pubmed-meshheading:21732929-Child,
pubmed-meshheading:21732929-Child, Preschool,
pubmed-meshheading:21732929-Globins,
pubmed-meshheading:21732929-Humans,
pubmed-meshheading:21732929-Infant,
pubmed-meshheading:21732929-Infant, Newborn,
pubmed-meshheading:21732929-Prognosis,
pubmed-meshheading:21732929-RNA Precursors,
pubmed-meshheading:21732929-RNA Splicing,
pubmed-meshheading:21732929-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21732929-Severity of Illness Index,
pubmed-meshheading:21732929-Thalassemia,
pubmed-meshheading:21732929-alpha-Globins,
pubmed-meshheading:21732929-beta-Globins
|
pubmed:year |
2011
|
pubmed:articleTitle |
Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of ?(E) pre-mRNA splicing determine disease severity.
|
pubmed:affiliation |
Thalassemia Research Centre, Institute of Molecular Biosciences, Mahidol University, Nakornpathom, Thailand.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|